Managing ADHD Medication "Crash" at End of Day

Primary Strategy: Afternoon Booster Dosing

The American Academy of Child and Adolescent Psychiatry recommends adding an immediate-release stimulant booster in the early afternoon to prevent rebound crash of symptoms when long-acting stimulants wear off, with a dosage of immediate-release methylphenidate 5-10 mg or immediate-release dextroamphetamine/mixed amphetamine salts 2.5-5 mg 1
The booster dose should be timed when symptoms return, not on a fixed schedule, and avoided after 3-4 PM to prevent insomnia, with the booster taking effect within 30 minutes and lasting 4-6 hours 1

Consider switching to OROS-MPH (Concerta) which provides 12 hours of continuous coverage, eliminating the need for afternoon dosing while maintaining symptom control, as recommended by treatment guidelines 1
Different extended-release methylphenidate formulations allow individualization of treatment to match when symptom relief is needed throughout the day, according to the American Academy of Child and Adolescent Psychiatry 2

Atomoxetine, guanfacine, or clonidine provide "around-the-clock" effects without the wearing-off phenomenon characteristic of stimulants, with smaller effect sizes than stimulants and taking 2-12 weeks to reach full efficacy, as stated by the American Academy of Child and Adolescent Psychiatry 2, 3
Clonidine or guanfacine can be added to stimulants as adjunctive therapy to control symptoms after the stimulant wears off and to counteract stimulant-induced insomnia, with a recommended starting dose of 0.05 mg at bedtime and increasing slowly, never exceeding 0.3 mg/day, according to the American Academy of Child and Adolescent Psychiatry 4

Monitor for cardiovascular effects (blood pressure and pulse) when implementing booster dosing, as recommended by the American Academy of Child and Adolescent Psychiatry 1
Monitor for appetite suppression throughout the day, as well as sleep disturbance and rebound irritability when medications wear off, according to the American Academy of Child and Adolescent Psychiatry 1, 2

Document that lower doses failed to control symptoms and confirm the combined regimen does not produce prohibitive side effects when prescribing combined long-acting plus booster regimens, as stated by the American Academy of Child and Adolescent Psychiatry 1
Establish monitoring protocols for tolerance when prescribing combined long-acting plus booster regimens, according to the American Academy of Child and Adolescent Psychiatry 1

Don't assume the crash is treatment failure, as stimulants have limited daily duration of effects and partial potential for rebound symptoms when wearing off is a known characteristic, as stated by the American Academy of Child and Adolescent Psychiatry 2
Don't overlook non-medication factors that worsen the crash, such as stress, inadequate nutrition, and sleep deprivation, according to the American Journal of Obstetrics and Gynecology 5